JP2003292459A5 - - Google Patents

Download PDF

Info

Publication number
JP2003292459A5
JP2003292459A5 JP2003059191A JP2003059191A JP2003292459A5 JP 2003292459 A5 JP2003292459 A5 JP 2003292459A5 JP 2003059191 A JP2003059191 A JP 2003059191A JP 2003059191 A JP2003059191 A JP 2003059191A JP 2003292459 A5 JP2003292459 A5 JP 2003292459A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003059191A
Other languages
Japanese (ja)
Other versions
JP2003292459A (ja
JP4740524B2 (ja
Filing date
Publication date
Priority claimed from TW91101510A external-priority patent/TWI299667B/zh
Priority claimed from CNB021032564A external-priority patent/CN1224424C/zh
Application filed filed Critical
Publication of JP2003292459A publication Critical patent/JP2003292459A/ja
Publication of JP2003292459A5 publication Critical patent/JP2003292459A5/ja
Application granted granted Critical
Publication of JP4740524B2 publication Critical patent/JP4740524B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003059191A 2002-01-30 2003-01-29 熱応答粘膜接着性医薬−担体組成物 Expired - Lifetime JP4740524B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
TW091101510 2002-01-30
TW91101510A TWI299667B (en) 2002-01-30 2002-01-30 A mucoadhesive thermoresponsive medicament-carrier composition
CNB021032564A CN1224424C (zh) 2002-02-01 2002-02-01 粘膜吸附性的热凝性医药载体组合物

Publications (3)

Publication Number Publication Date
JP2003292459A JP2003292459A (ja) 2003-10-15
JP2003292459A5 true JP2003292459A5 (enExample) 2005-10-27
JP4740524B2 JP4740524B2 (ja) 2011-08-03

Family

ID=30116452

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003059191A Expired - Lifetime JP4740524B2 (ja) 2002-01-30 2003-01-29 熱応答粘膜接着性医薬−担体組成物

Country Status (2)

Country Link
US (2) US20040009212A1 (enExample)
JP (1) JP4740524B2 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005046587A2 (en) 2003-11-08 2005-05-26 Prothera Biologics Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
CA2595377A1 (en) 2005-01-28 2006-08-03 Children's Medical Center Corporation Methods for diagnosis and prognosis of epithelial cancers
US7851189B2 (en) 2005-03-07 2010-12-14 Boston Scientific Scimed, Inc. Microencapsulated compositions for endoluminal tissue engineering
US20070082048A1 (en) * 2005-06-08 2007-04-12 Ronald Warner Sleep aid formulations
US20080279921A1 (en) * 2007-05-07 2008-11-13 Ceramoptec Industries, Inc. Gel-formulations of hydrophobic photosensitizers for mucosal applications
EP2034963B1 (en) * 2006-05-18 2022-08-10 biolitec Unternehmensbeteiligungs II AG Gel-formulations of hydrophobic photosensitizers for mucosal applications
WO2009073457A1 (en) * 2007-11-30 2009-06-11 Bausch & Lomb Incorporated Methods and compositions for the rescue of a filtering bleb
KR101828433B1 (ko) 2008-05-28 2018-03-29 프로테라 바이오로직스, 인크. 혈액으로부터 인터-알파 저해 단백질의 제조 및 조성물
KR100935711B1 (ko) 2008-09-12 2010-01-07 김희구 생약 패드
GB0823472D0 (en) * 2008-12-23 2009-01-28 Photocure Asa Product
US20100256125A1 (en) * 2009-04-06 2010-10-07 Zila Pharmaceuticals, Inc. Use of improved toluidine blue in photodynamic therapy
MX2011013127A (es) * 2009-06-11 2012-02-21 Photocure Asa Composiciones semi-solidas y productos farmaceuticos.
CA2767612A1 (en) 2009-07-10 2011-01-13 Thrombogenics Nv Variants of plasminogen and plasmin
EP2480249B1 (en) * 2009-08-28 2015-01-28 ThromboGenics N.V. Plasmin for the treatment of filtration failure after trabeculectomy
HRP20181266T1 (hr) 2009-10-01 2018-10-05 Adare Pharmaceuticals, Inc. Kortikosteroidni pripravci za oralnu primjenu
US10471150B2 (en) 2010-01-20 2019-11-12 Urogen Pharma Ltd. Material and method for treating internal cavities
WO2011089604A2 (en) 2010-01-20 2011-07-28 Theracoat Ltd Material and method for treating internal cavities
RU2604807C2 (ru) 2011-01-05 2016-12-10 ТромбоДженикс НВ Варианты плазминогена и плазмина
CA2829241A1 (en) 2011-04-01 2012-10-04 University Of Florida Research Foundation, Inc. Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
WO2013011504A1 (en) * 2011-07-20 2013-01-24 Theracoat Ltd. Materials and method for treating internal body cavities
RU2604810C2 (ru) 2011-08-12 2016-12-10 Тромбодженикс Н.В. Варианты плазминогена и плазмина
DK2836200T3 (da) * 2012-04-08 2020-09-21 Urogen Pharma Ltd Termoreversible hydrogelpræparater til anvendelse i behandlingen af lidelser i urothelium
FR2994844B1 (fr) * 2012-08-31 2015-01-02 Assist Publ Hopitaux De Paris Formulation gelifiante a base de ketamine
US9572872B2 (en) 2012-09-09 2017-02-21 Prothera Biologics, Inc. Treatment of disease using inter-alpha inhibitor proteins
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
US9801854B1 (en) * 2014-01-17 2017-10-31 Urogen Pharma Ltd. Slow release formulations of cell cycle regulators and anti-cancer agents for local treatment of solid cancer
AR100864A1 (es) * 2014-06-09 2016-11-09 Klox Tech Inc Composiciones biofotónicas termoendurecibles y sus usos
BR112017002580A2 (pt) 2014-08-11 2018-03-27 Univ Louisiana State administração de antioxidantes bioativos nanoencapsulados
DE102016001176A1 (de) * 2016-02-03 2017-08-03 Audi Ag Kraftfahrzeug
TWI777515B (zh) 2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
CA3036553A1 (en) 2016-09-13 2018-03-22 Prothera Biologics, Inc. Methods for treating pulmonary disease using inter-alpha inhibitor proteins
CN110691973B (zh) 2017-04-25 2024-11-29 普罗瑟拉生物公司 用于定量间α抑制剂蛋白的方法
US12251378B2 (en) 2018-05-08 2025-03-18 University Of Connecticut Long-acting local anesthetic formulation
EP3833401A4 (en) * 2018-08-06 2022-04-27 Oregon Health & Science University NERVE-SPECIFIC FLUOROPHORUS FORMULATIONS FOR DIRECT AND SYSTEMIC DELIVERY
EP3854422B1 (en) * 2018-09-20 2025-01-22 FUJIFILM Corporation Biomaterial
CN112043827B (zh) * 2019-05-20 2023-10-20 复旦大学 温敏性药物组合物、透皮制剂及其制备方法和应用
JP2023553976A (ja) 2020-12-11 2023-12-26 ウロゲン ファーマ リミテッド がんを治療するための材料及び方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0551626A1 (en) * 1991-12-19 1993-07-21 LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
JPH08175986A (ja) * 1994-09-20 1996-07-09 Johnson & Johnson Medical Inc 経皮活性を示す5−アミノレブリン酸含有薬学組成物
US6280745B1 (en) * 1997-12-23 2001-08-28 Alliance Pharmaceutical Corp. Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions
DE19744811C2 (de) * 1997-10-02 1999-11-18 Medac Klinische Spezialpraep Verwendung von delta-Aminolävulinsäure zur Herstellung eines topischen Arzneimittels zur integralen Diagnose und/oder Therapie von Tumoren in Hohlorganen
EP1140091B1 (en) * 1999-01-08 2005-09-21 3M Innovative Properties Company Formulations comprising imiquimod or other immune response modifiers for treating cervical dysplasia
WO2000041732A1 (en) * 1999-01-19 2000-07-20 The Children's Hospital Of Philadelphia Hydrogel compositions for controlled delivery of virus vectors and methods of use thereof

Similar Documents

Publication Publication Date Title
BE2013C075I2 (enExample)
BE2013C069I2 (enExample)
BE2013C067I2 (enExample)
BE2013C038I2 (enExample)
BE2013C036I2 (enExample)
JP2003310537A5 (enExample)
BE2011C030I2 (enExample)
IN2004MU00746A (enExample)
BE2013C034I2 (enExample)
JP2003292459A5 (enExample)
JP2004221348A5 (enExample)
BE2012C053I2 (enExample)
JP2003299632A5 (enExample)
JP2003247632A5 (enExample)
JP2004087457A5 (enExample)
JP2003323159A5 (enExample)
JP2004029736A5 (enExample)
JP2004221218A5 (enExample)
JP2004149216A5 (enExample)
JP2004206041A5 (enExample)
DE602004032111D1 (enExample)
JP2003245772A5 (enExample)
JP2003199955A5 (enExample)
AU2002331433A1 (enExample)
AU2002249912A1 (enExample)